Neda Rasouli, MD
Endocrinology, Diabetes & Metabolism · Aurora, CONPI 1336247295
Payments from drug & device makers
Across 4,484 payments — averaging $1499.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$3.7M
- Novo Nordisk AS$2.4M
- Novo Nordisk$518K
- AbbVie$101K
- Boehringer Ingelheim$6K
- Sanofi-aventis U.S. LLC$5K
- plus $9K from 15 others
Across 40 payments — averaging $2821.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$101K
- Novo Nordisk$9K
- Novo Nordisk AS$3K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 232 | $3,719,450 |
| Novo Nordisk AS | 4,094 | $2,365,570 |
| Novo Nordisk | 59 | $518,042 |
| AbbVie | 56 | $100,767 |
| Boehringer Ingelheim | 2 | $6,000 |
| Sanofi-aventis U.S. LLC | 5 | $5,387 |
| Amgen | 3 | $3,756 |
| Medtronic(3 entities) | 19 | $2,219 |
| Boehringer Ingelheim International GmbH | 1 | $1,800 |
| Abbott | 1 | $300 |
| Biotronik Inc. | 2 | $231 |
| Cvrx, Inc. | 1 | $209 |
| Nevro Corp. | 1 | $150 |
| Cardiovascular Systems Inc. | 1 | $145 |
| Terumo Medical Corporation | 1 | $128 |
| Philips North America LLC | 1 | $125 |
| Rhythm Pharmaceuticals, Inc. | 1 | $118 |
| Bayer | 1 | $111 |
| Boehringer Ingelheim France S.a.s. | 1 | $35 |
| Renalytix AI, Inc. | 1 | $34 |
| Mannkind Corporation | 1 | $28 |
How this compares
$6,724,605 in reported general payments places this provider in the 95th percentile of 120 endocrinology, diabetes & metabolism providers in Colorado.
See all endocrinology, diabetes & metabolism providers in Colorado →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Aurora
- Satish GargAurora$8.6M
- Viralkumar ShahAurora$2.1M
- Halis AkturkAurora$1.8M
- Bryan HaugenAurora$714K
- Sarit PolskyAurora$575K
- Marc Andre CornierAurora$475K
- Holly WyattAurora$465K
- Whitney GoldnerAurora$386K
- Peter GottliebAurora$335K
- David SaxonAurora$165K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.